Overview

Saved From COVID-19

Status:
Terminated

Trial end date:
2021-01-07

Target enrollment:

Participant gender:

Summary

The primary objective is to determine the clinical efficacy of Chloroquine (CQ) in health care workers with moderate to high risk of exposure to COVID-19 in preventing symptomatic COVID-19 infections. Secondary endpoints will explore the efficacy of CQ in preventing any infection as defined by seroconversion to positive anti-COVID antibody status.

Phase:

Phase 2

Details

Lead Sponsor:

Columbia University

Treatments:

Chloroquine